These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36190346)

  • 21. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study.
    Ruffatti A; Salvan E; Del Ross T; Gerosa M; Andreoli L; Maina A; Alijotas-Reig J; De Carolis S; Mekinian A; Bertero MT; Canti V; Brucato A; Bremme K; Ramoni V; Mosca M; Di Poi E; Caramaschi P; Galeazzi M; Tincani A; Trespidi L
    Thromb Haemost; 2014 Oct; 112(4):727-35. PubMed ID: 25008944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome].
    Gu JY; Lu C; Shi H; Yang CD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1033-1038. PubMed ID: 30562777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
    Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
    Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extra-criteria manifestations of antiphospholipid syndrome: Risk assessment and management.
    Radin M; Ugolini-Lopes MR; Sciascia S; Andrade D
    Semin Arthritis Rheum; 2018 Aug; 48(1):117-120. PubMed ID: 29395258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study.
    Bucci T; Ames PRJ; Triggiani M; Parente R; Ciampa A; Pignatelli P; Pastori D;
    Thromb Res; 2022 Jan; 209():69-74. PubMed ID: 34891057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypes in antiphospholipid syndrome: A hierarchical cluster analysis based on two independent databases.
    Taieb D; Moyon Q; Lhote R; Annesi-Maesano I; Haroche J; Cervera R; Amoura Z; Cohen Aubart F
    J Autoimmun; 2024 Apr; 144():103173. PubMed ID: 38330544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome].
    Zhao JL; Sun YD; Zhang Y; Xu D; Wang Q; Li MT; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):386-91. PubMed ID: 27143190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of non-criteria antiphospholipid antibodies titers among patients with antiphospholipid syndrome and patients with systemic lupus erythematosus.
    Urrego-Callejas T; Hernández A; Ruiz Giraldo S; Frade-Sosa B; Vanegas-García AL; Muñoz CH; Rua C; Duque Botero J; González LA; Vásquez G; Gómez-Puerta JA
    Reumatol Clin (Engl Ed); 2023 Apr; 19(4):197-203. PubMed ID: 37061281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical characteristics of 37 antiphospholipid syndrome patients complicated by autoimmune hemolytic anemia].
    Zhang JT; Qi WT; Zhou YZ; Huang C; Zhao JL; Li MT; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2023 Feb; 62(2):147-155. PubMed ID: 36740405
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk factors for arterial thrombosis in antiphospholipid syndrome.
    Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J
    Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE.
    Elbagir S; Grosso G; Mohammed NA; Elshafie AI; Elagib EM; Zickert A; Manivel VA; Pertsinidou E; Nur MAM; Gunnarsson I; Rönnelid J; Svenungsson E
    Lupus; 2021 Jul; 30(8):1289-1299. PubMed ID: 33957795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antiphospholipid syndrome - often overlooked cause of vascular occlusions?
    Svenungsson E; Antovic A
    J Intern Med; 2020 Apr; 287(4):349-372. PubMed ID: 31957081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the 2006 revised antiphospholipid syndrome classification criteria.
    Kaul M; Erkan D; Sammaritano L; Lockshin MD
    Ann Rheum Dis; 2007 Jul; 66(7):927-30. PubMed ID: 17337473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome.
    Truglia S; Capozzi A; Mancuso S; Manganelli V; Rapino L; Riitano G; Recalchi S; Colafrancesco S; Ceccarelli F; Garofalo T; Alessandri C; Longo A; Misasi R; Conti F; Sorice M
    Front Immunol; 2022; 13():932181. PubMed ID: 35860235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis.
    Dufrost V; Risse J; Reshetnyak T; Satybaldyeva M; Du Y; Yan XX; Salta S; Gerotziafas G; Jing ZC; Elalamy I; Wahl D; Zuily S
    Autoimmun Rev; 2018 Oct; 17(10):1011-1021. PubMed ID: 30103045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohort of 214 patients.
    Paule R; Morel N; Le Guern V; Fredi M; Coutte L; Belhocine M; Mouthon L; le Jeunne C; Chauvin A; Piette JC; Costedoat-Chalumeau N
    Autoimmun Rev; 2018 Sep; 17(9):866-872. PubMed ID: 30005859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and treatment of APS renal involvement.
    Tektonidou MG
    Lupus; 2014 Oct; 23(12):1276-8. PubMed ID: 25228725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of the antiphospholipid syndrome and its effect on survival in 679 Chinese patients with systemic lupus erythematosus: a cohort study.
    Mok CC; Chan PT; Ho LY; Yu KL; To CH
    Medicine (Baltimore); 2013 Jul; 92(4):217-222. PubMed ID: 23793109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiphospholipid syndrome: An update on risk factors for pregnancy outcome.
    De Carolis S; Tabacco S; Rizzo F; Giannini A; Botta A; Salvi S; Garufi C; Benedetti Panici P; Lanzone A
    Autoimmun Rev; 2018 Oct; 17(10):956-966. PubMed ID: 30118899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.